The prognostic value of the AST/ALT ratio has been increasingly recognized across a range of extrahepatic diseases, including cardiac arrest, ischemic stroke, and renal cell carcinoma, where higher values are associated with increased ICU admission and mortality [29–31]. Here, GPT is linked to hereditary clear cell renal cell carcinoma.